Company / Dividends Paid
Bristol Myers Squibb Dividends Paid History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Dividends Paid
$5.0B
FY2025
5-year range
$2.7B / $5.0B
FY2021-FY2025
Trend
+3.7%
vs FY2024
Sector context
#5 of 12
Health Care
What the data says
At $5.0B, Bristol Myers Squibb's dividends paid ranks #5 of 12 in the Health Care sector. Dividends Paid has increased for 4 consecutive years, from $2.7B in FY2021 to $5.0B in FY2025.
Based on SEC 10-K filings.
$5.0B in FY2025 with a 5-year CAGR of +4.4%.
Improved from $4.4B to $5.0B over the past 2 years.
Health Care sector context is included.
Dividends Paid over time
Growth rates
- 3-Year CAGR
- +7.4%
- 5-Year CAGR
- +4.4%
- 10-Year CAGR
- -
Sector benchmark
#5 of 12 in Health CareTop 42% of 12This company $5.0B Sector average $3.3B
▼
+51.2% above sector average
Key checks
Key Insights
- Bristol Myers Squibb's dividends paid has grown for 4 consecutive years.
- 5-year CAGR of +4.4%, indicating consistent growth.
- In FY2025, dividends paid increased 3.7% year-over-year.
- Ranks #5 out of 12 companies in the Health Care sector.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Dividends PaidValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.0B | +3.7% |
| FY2024 | $4.9B | +10.6% |
| FY2023 | $4.4B | +7.9% |
| FY2022 | $4.1B | +52.1% |
| FY2021 | $2.7B | -34.3% |
| FY2020 | $4.1B | +58.1% |
| FY2019 | $2.6B | +1.2% |
| FY2018 | $2.5B | -1.2% |
| FY2017 | $2.6B | +7.5% |
| FY2016 | $2.4B | +3.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026